News
Sarepta, Gene Therapy
Digest more
Our Bureau, Mumbai Friday, July 18, 2025, 17:45 Hrs [IST] ...
CMS is brokering outcomes-based agreements on behalf of Medicaid programs. Thirty-three states, along with Washington, D.C., ...
Groundbreaking new research shows that it is possible to use gene therapy to restore hearing in both children and adults.
The manufacturing-related rejection for UX111 is more than a setback for Ultragenyx, as it also delays a key test of the new ...
22h
InvestorsHub on MSNRocket Pharmaceuticals Shares Jump After FDA Grants Accelerated Review Status to Gene TherapyRocket Pharmaceuticals Inc. (NASDAQ:RCKT) surged 15% after receiving a key regulatory boost from the U.S. Food and Drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results